JP2021153588A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021153588A5 JP2021153588A5 JP2021092115A JP2021092115A JP2021153588A5 JP 2021153588 A5 JP2021153588 A5 JP 2021153588A5 JP 2021092115 A JP2021092115 A JP 2021092115A JP 2021092115 A JP2021092115 A JP 2021092115A JP 2021153588 A5 JP2021153588 A5 JP 2021153588A5
- Authority
- JP
- Japan
- Prior art keywords
- artificial
- sequence
- molecules
- family
- standard set
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108020004707 nucleic acids Proteins 0.000 claims 42
- 150000007523 nucleic acids Chemical class 0.000 claims 42
- 102000039446 nucleic acids Human genes 0.000 claims 42
- 239000002773 nucleotide Substances 0.000 claims 5
- 125000003729 nucleotide group Chemical group 0.000 claims 5
- 108700024394 Exon Proteins 0.000 claims 4
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 claims 4
- 108020005067 RNA Splice Sites Proteins 0.000 claims 4
- 239000003795 chemical substances by application Substances 0.000 claims 4
- 230000000977 initiatory effect Effects 0.000 claims 4
- 230000035897 transcription Effects 0.000 claims 4
- 238000013518 transcription Methods 0.000 claims 4
- 108700005078 Synthetic Genes Proteins 0.000 claims 3
- 108020005544 Antisense RNA Proteins 0.000 claims 2
- MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 claims 2
- NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 claims 2
- 108091092195 Intron Proteins 0.000 claims 2
- 230000007717 exclusion Effects 0.000 claims 2
- 239000012634 fragment Substances 0.000 claims 2
- 229940029575 guanosine Drugs 0.000 claims 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims 1
- 108020004414 DNA Proteins 0.000 claims 1
- 238000001035 drying Methods 0.000 claims 1
- 238000001914 filtration Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14176417 | 2014-07-09 | ||
| EP14176417.5 | 2014-07-09 | ||
| JP2017501008A JP6930910B2 (ja) | 2014-07-09 | 2015-07-09 | Ｒｎａ転写産物バリアントを定量するための方法及び製品 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017501008A Division JP6930910B2 (ja) | 2014-07-09 | 2015-07-09 | Ｒｎａ転写産物バリアントを定量するための方法及び製品 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021153588A JP2021153588A (ja) | 2021-10-07 |
| JP2021153588A5 true JP2021153588A5 (enExample) | 2021-11-18 |
| JP7568581B2 JP7568581B2 (ja) | 2024-10-16 |
Family
ID=51224706
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017501008A Active JP6930910B2 (ja) | 2014-07-09 | 2015-07-09 | Ｒｎａ転写産物バリアントを定量するための方法及び製品 |
| JP2019182851A Pending JP2020014478A (ja) | 2014-07-09 | 2019-10-03 | Ｒｎａ転写産物バリアントを定量するための方法及び製品 |
| JP2021092115A Active JP7568581B2 (ja) | 2014-07-09 | 2021-06-01 | Ｒｎａ転写産物バリアントを定量するための方法及び製品 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017501008A Active JP6930910B2 (ja) | 2014-07-09 | 2015-07-09 | Ｒｎａ転写産物バリアントを定量するための方法及び製品 |
| JP2019182851A Pending JP2020014478A (ja) | 2014-07-09 | 2019-10-03 | Ｒｎａ転写産物バリアントを定量するための方法及び製品 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US10513726B2 (enExample) |
| EP (1) | EP3167076B1 (enExample) |
| JP (3) | JP6930910B2 (enExample) |
| KR (1) | KR102555447B1 (enExample) |
| CN (1) | CN106471134B (enExample) |
| AU (1) | AU2015286672B2 (enExample) |
| CA (1) | CA2954495C (enExample) |
| DK (1) | DK3167076T3 (enExample) |
| LT (1) | LT3167076T (enExample) |
| WO (1) | WO2016005524A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013038010A2 (en) | 2011-09-16 | 2013-03-21 | Lexogen Gmbh | Nucleic acid transcription method |
| CN106471134B (zh) | 2014-07-09 | 2021-11-12 | 莱科赛根有限公司 | 用于定量rna转录物变体的方法和产物 |
| CN106771194B (zh) * | 2017-01-18 | 2018-07-20 | 青岛大学 | 一种检测病原微生物的方法 |
| AU2018225180B2 (en) | 2017-02-22 | 2024-09-12 | Io Biosciences, Inc. | Nucleic acid constructs comprising gene editing multi-sites and uses thereof |
| US10828330B2 (en) * | 2017-02-22 | 2020-11-10 | IO Bioscience, Inc. | Nucleic acid constructs comprising gene editing multi-sites and uses thereof |
| SE541799C2 (en) * | 2018-04-11 | 2019-12-17 | David Yudovich | Determination of frequency distribution of nucleotide sequence variants |
| CA3097004A1 (en) | 2018-04-17 | 2019-10-24 | The Trustees Of The University Of Pennsylvania | Trans-splicing molecules |
| CN116479137A (zh) * | 2018-05-02 | 2023-07-25 | 宁夏农林科学院动物科学研究所 | 一种基于snp位点组合鉴定滩羊的方法 |
| EP3666904A1 (en) | 2018-12-14 | 2020-06-17 | Lexogen GmbH | Nucleic acid amplification and identification method |
| EP3901284A1 (en) * | 2020-04-20 | 2021-10-27 | BMBK Invest BV | Construct, kit and method for sample tracking |
| KR102690574B1 (ko) | 2020-06-26 | 2024-07-31 | 숙명여자대학교산학협력단 | 비타민 b1의 보호 및 전달을 위한 장용성 조성물 |
| KR102690573B1 (ko) | 2020-06-26 | 2024-07-31 | 숙명여자대학교산학협력단 | 사이클로덱스트린을 이용한 경구투여용 복합 조성물 및 이의 제조방법 |
| WO2023086441A1 (en) * | 2021-11-12 | 2023-05-19 | Regents Of The University Of Minnesota | Compositions and methods for transcriptional activation |
| EP4438741A4 (en) * | 2021-11-26 | 2025-08-06 | Daan Gene Co Ltd | HIGH-THROUGHPUT SEQUENCING METHOD BASED ON THE INTERNAL REFERENCE OF A KNOWN MARKER |
| GB2634434A (en) * | 2022-05-13 | 2025-04-09 | Ascidian Therapeutics Inc | ABCA4 trans-splicing molecules |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2593343B1 (fr) | 1986-01-20 | 1988-03-25 | Thomson Csf | Matrice d'elements photosensibles et son procede de fabrication, procede de lecture associe, et application de cette matrice a la prise de vue d'images |
| WO2002072889A2 (en) | 2001-01-12 | 2002-09-19 | Applera Corporation | Methods and compositions for microarray control |
| EP1386009A4 (en) | 2001-05-07 | 2005-04-27 | Amersham Biosciences Corp | CONSTRUCTION OF ARTIFICIAL GENES FOR USE AS CONTROLS IN GENE EXPRESSION ANALYSIS SYSTEMS |
| US20040009512A1 (en) | 2002-05-02 | 2004-01-15 | Manuel Ares | Arrays for detection of products of mRNA splicing |
| WO2005086938A2 (en) * | 2004-03-11 | 2005-09-22 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention | Artificial mutation controls for diagnostic testing |
| EP2333104A1 (en) * | 2009-12-11 | 2011-06-15 | Lexogen GmbH | RNA analytics method |
| CN106471134B (zh) | 2014-07-09 | 2021-11-12 | 莱科赛根有限公司 | 用于定量rna转录物变体的方法和产物 |
-
2015
- 2015-07-09 CN CN201580035408.5A patent/CN106471134B/zh active Active
- 2015-07-09 WO PCT/EP2015/065756 patent/WO2016005524A1/en not_active Ceased
- 2015-07-09 AU AU2015286672A patent/AU2015286672B2/en active Active
- 2015-07-09 CA CA2954495A patent/CA2954495C/en active Active
- 2015-07-09 JP JP2017501008A patent/JP6930910B2/ja active Active
- 2015-07-09 LT LTEPPCT/EP2015/065756T patent/LT3167076T/lt unknown
- 2015-07-09 US US15/323,951 patent/US10513726B2/en active Active
- 2015-07-09 EP EP15736490.2A patent/EP3167076B1/en active Active
- 2015-07-09 DK DK15736490.2T patent/DK3167076T3/da active
- 2015-07-09 KR KR1020177002619A patent/KR102555447B1/ko active Active
-
2019
- 2019-10-03 JP JP2019182851A patent/JP2020014478A/ja active Pending
-
2021
- 2021-06-01 JP JP2021092115A patent/JP7568581B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021153588A5 (enExample) | ||
| McMullen et al. | The structure of the maize ribosomal DNA spacer region | |
| JP2023523237A (ja) | ｓｎＲＮＡ構成要素を使用する組成物及び方法 | |
| KR101785847B1 (ko) | 선형 이중가닥 ＤＮＡ를 활용한 ＣＲＩＳＰＲ／Ｃａｓ９ 시스템을 이용한 표적 유전체 교정 | |
| Riley et al. | Multiple guide RNAs for identical editing of Trypanosoma brucei apocytochrome b mRNA have an unusual minicircle location and are developmentally regulated. | |
| JP2015518714A5 (enExample) | ||
| JP2020188756A5 (enExample) | ||
| JP2015518710A5 (enExample) | ||
| JP2016522674A5 (enExample) | ||
| JP2018534950A5 (enExample) | ||
| CN108350454A (zh) | 等位基因选择性基因编辑及其用途 | |
| AU2017235333A1 (en) | CRISPR/CAS-related methods and compositions for treating beta hemoglobinopathies | |
| JP2021502060A5 (enExample) | ||
| RU2012125364A (ru) | Лечение заболеваний регуляторного фактора интерферона 8 (irf8) путем ингибирования природного антисмыслового транскрипта к irf8 | |
| RU2013115853A (ru) | Лечение заболеваний, связанных с геном альфа-l-идуронидазы (idua), путем ингибирования природного антисмыслового транскрипта гена idua | |
| JP2015518711A5 (enExample) | ||
| JP2009532392A5 (enExample) | ||
| JP2015523853A5 (enExample) | ||
| EP1544297A3 (en) | Medicament for treatment of Duchenne muscular dystrophy | |
| RU2013116353A (ru) | Лечение заболеваний, связанных с интерферон- связанным регулятором развития 1(ifrd1), путем ингибирования природного антисмыслового транскрипта к ifrd1 | |
| RU2016115782A (ru) | Лечение заболеваний, связанных с субстратом рецептора инсулина 2 (irs2), путем ингибирования природного антисмыслового транскрипта к irs2 и транскрипционному фактору е3 (tfe3) | |
| Peres et al. | Association between PAX-9 promoter polymorphisms and hypodontia in humans | |
| Tensen et al. | Genomic organization, sequence and transcriptional regulation of the human CXCL 11 gene | |
| JPWO2020163755A5 (enExample) | ||
| Din et al. | The nucleotide sequence at the transcription termination site of the ribosomal RNA gene in Tetrahymena thermophila |